Gilead and Galapagos to Present Latest Data on Filgotinib at the Annual European Congress of Rheumatology (EULAR 2019)
— Phase 3 FINCH 1 and FINCH 3 Data of Filgotinib in Rheumatoid Arthritis to Be Featured in Opening Plenary…
Pharmaceuticals, Biotechnology and Life Sciences
— Phase 3 FINCH 1 and FINCH 3 Data of Filgotinib in Rheumatoid Arthritis to Be Featured in Opening Plenary…
LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President…
Total Revenues of $244.8M, up 25% Year-over-year;Subscription Services Revenues of $198.1M, up 27% Year-over-year PLEASANTON, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/LifeSciences?src=hash" target="_blank"gt;#LifeScienceslt;/agt;–Veeva Systems…
̶ Presentations to be webcast on www.exelixis.com ̶ ALAMEDA, Calif.–(BUSINESS WIRE)–Exelixis, Inc. (Nasdaq: EXEL) today announced that the company will be presenting…
ROCKVILLE, Md.–(BUSINESS WIRE)–GlycoMimetics, Inc. (Nasdaq: GLYC) today announced that Chief Executive Officer Rachel King will provide a corporate update at…
WASHINGTON–(BUSINESS WIRE)–The Biotechnology Innovation Organization (BIO) is pleased to announce the winner of this year’s Henri A. Termeer Biotechnology Visionary…
World-class facility will offer the Company nearly three times the space for disruptive biomarker technology innovation and to accommodate growing…
Global Event in Boston, August 12-16, Provides New Data, Technologies, and Collaboration Opportunities BOSTON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/BPSMT?src=hash" target="_blank"gt;#BPSMTlt;/agt;–With cell and gene…
SAN DIEGO–(BUSINESS WIRE)–Cytonus Therapeutics Inc., a biotechnology company developing new platforms for delivering biologics, announced today that it will be…
DUBLIN–(BUSINESS WIRE)–The “Regulatory Affairs for Support Staff” conference has been added to ResearchAndMarkets.com’s offering. This two-day course provides an introduction…